Botox gains FDA approval for axillary hyperhidrosis; off-label use has been fairly common.

This digital document is an article from Skin & Allergy News, published by International Medical News Group on September 1, 2004. The length of the article is 584 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Botox gains FDA approval for axillary hyperhidrosis; off-label use has been fairly common.(Food and Drug Administration)(botulinum toxin type A)Author: Kate JohnsonPublication: Skin & Allergy News (Magazine/Journal)Date: September 1, 2004Publisher: International Medical News GroupVolume: 35 Issue: 9 Page: 1(2)Distributed by T…
Click Here For Big Discounts On Botox gains FDA approval for axillary hyperhidrosis; off-label use has been fairly common. at Amazon

Tagged with: Approval • axillary • been • Botox • common. • fairly • gains • hyperhidrosis. • offlabel